Advanced Filters
noise
Found 65,447 clinical trials
M Mariana Garcia, Investigador

The Effect of Accompaniment by Older Adults on Anesthetic Recovery

Summary In 2022, Mexico estimated a population of 17,958,707 older adults. With increased life expectancy, it is essential to seek strategies that improve the health of this population, as they are more vulnerable compared to other age groups due to functional and cognitive decline, along with an increase in chronic …

60 years of age All Phase N/A
A Ahmad Mamdouh, Professor

Management of Non-Organic Dysphonia in Adults.

The purpose of this study is to determine the effect of a semi-occluded vocal tract training program, "Resonant Tube Therapy," versus the "Traditional Smith-accent Method" on the quality of voice in patients with Non-Organic "Functional" dysphonia.

15 - 60 years of age All Phase N/A
C Carol Kwong, RN

De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE)

The goal of this prospective clinical trial is to determine if HPV-associated oropharyngeal squamous cell carcinoma that is non-hypoxic on FMISO PET can be successfully treated with a lower dose of radiation therapy. The main questions it aims to answer are: What is the pathologic complete response rate in patients …

18 years of age All Phase N/A
A Alejandro Padilla Isassi, Geriatrician

Impact of NANO-PSO on Cognition in Older Adults with Mild to Moderate Cognitive Impairment

The objective of this randomized, triple-blind, placebo-controlled clinical trial is to compare NANO-PSO therapy against placebo in improving cognitive abilities in older adults with mild to moderate non-vascular cognitive impairment over six months of treatment. The primary questions it aims to answer are: • Does NANO-PSO therapy improve cognitive abilities …

60 years of age All Phase 2
G Gevher Rabia Genç Perdecioğlu

Posterior Tibial Nerve PRF for Painful Calcaneal Fracture

Patients who underwent pulsed radiofrequency (PRF) treatment of the posterior tibial nerve under ultrasound guidance, which is routinely performed in our clinic for severe heel pain following a calcaneal fracture, were evaluated through interviews. The assessment was conducted using the Visual Analog Scale (VAS) for pain and the American Orthopaedic …

18 - 80 years of age All Phase N/A
F Frede Donskov, Professor

Mediterranean Diet and Inequality in Early Breast Cancer

Social determinants such as education, income, marital status, and social networks play a crucial role in cancer outcomes, including breast cancer. One potential influencing factor is diet, and the Mediterranean diet has been shown to benefit both the health and the microbiome. This raises the question: Does adherence to the …

18 years of age All Phase 2
H Hani Steinberg, RN

Modified Vaccine for High Risk or Low Residual Melanoma Patients

This study is designed for patients who had malignant melanoma and, following tumor removal, are now free of disease, or have only very minor residual disease, and are at a very high risk of disease recurrence. These patients will be treated with the A2/4-1BBL melanoma vaccine, a compatible melanoma cell …

years of age All Phase 1/2
S Site Contact

A Study of YKST02 in Participants with Relapsed or Refractory Multiple Myeloma

This study aims to provide a basis for further clinical development of YKST02. YKST02 is a study medicine that targets multiple myeloma and activates the human body to fight against this disease.

18 - 75 years of age All Phase 1
E Elise Nelson

ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.

Patient with moderate-to-severe plaque psoriasis will receive Ilumya with or without Halog ointment.

18 years of age All Phase 4
T Tangfeng Lv

Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer

Lung cancer is the leading cause of morbidity and mortality in the world, of which 80%-85% are non-small cell lung cancer (NSCLC). Most patients with NSCLC are at the advanced stage of diagnosis and have a poor prognosis. The 5-year survival rate of stage III patients is about 15%, the …

18 years of age All Phase 1

Simplify language using AI